We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Published in Cardiology

Journal Scan / Research · July 12, 2020

No Advantages of Self-Expanding Intra-Annular Transcatheter Heart Valves in High-Risk Patients With Severe Aortic Stenosis

The Lancet


Additional Info

The Lancet
Self-Expanding Intra-Annular Versus Commercially Available Transcatheter Heart Valves in High and Extreme Risk Patients With Severe Aortic Stenosis (PORTICO IDE): A Randomised, Controlled, Non-inferiority Trial
Lancet 2020 Jun 25;[EPub Ahead of Print], RR Makkar, W Cheng, R Waksman, LF Satler, T Chakravarty, M Groh, W Abernethy, MJ Russo, D Heimansohn, J Hermiller, S Worthley, B Chehab, M Cunningham, R Matthews, RK Ramana, G Yong, CE Ruiz, C Chen, FM Asch, M Nakamura, H Jilaihawi, R Sharma, SH Yoon, AD Pichard, S Kapadia, MJ Reardon, DL Bhatt, GP Fontana

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading